Click here to read the previous top ASX cannabis stocks article.

While the Australian cannabis industry continues its progress overall, investors have been able to also see the advancements in the open market.


There are many steps needed for the industry in Australia to flourish even more, in the meantime the following cannabis companies have made the most of 2021 in the stock market at the halfway mark for the year.

Here the Investing News Network (INN) takes a closer look at some of the top gainers in the Australian cannabis stock market. The data for this list was collected following markets closing on June 30, 2021.

 

Cannabis Market Could Reach $5.5B By End Of Year

 
Experts Weigh In On Our Exclusive FREE Report. Can You Afford To Miss Out?
 

1. IDT Australia (ASX:IDT)

Year-to-date gain: 73.68 percent; current market cap: AU$164.30 million; current share price: AU$0.33

This Victoria-based medical company has an output into the medical cannabis industry through its licenses and manufacturing capabilities for. These opportunities manifest for the company in the domestic market and through international ventures, like in its most recent partnership.

In June, the company announced a deal with Clever Leaves Holding (NASDAQ:CLVR) to supply two separate varieties of cannabis flower.

“Clever Leaves is a dependable and reputable supplier which meets IDT’s stringent cGMP requirements and we see this partnership as a strategic solution which creates a great opportunity for both companies,” IDT’s CEO Dr. David Sparling said.

2. Incannex Healthcare (ASX:IHL)

Year-to-date gain: 66.67 percent; current market cap: AU$396.41 million; current share price: AU$0.25

Previously known as Impression Healthcare, Incannex Healthcare is a medical company developing cannabinoid medicine. Recently the firm has expanded into more medicine options, including investigating psilocybin for treatment of Generalised Anxiety Disorder.

The company holds a license allowing it to import, export and distribute medical cannabis products.

In the time since the first half of the year wrapped up, the company announced its plans to secure a listing in the US through the NASDAQ.

3. Little Green Pharma (LGP) (ASX:LGP)

Year-to-date gain: 57.14 percent; current market cap: AU$125.52M million; current share price: AU$0.88

LGP is a vertically integrated medicinal cannabis operator with growing and exporting capabilities of medical products.

This year, the firm has had a bigger push on the international front with successful ventures into Germany and France. Additionally the producer acquired a cannabis facility in Denmark to support its European plans.

“We are well positioned in the market to capitalise on the brand equity LGP has built in Europe and Australia, with the Denmark Facility providing immediate access to medical grade product at volumes that will allow us the opportunity to accelerate our growth strategy,” Fleta Solomon, LGP’s managing director, said.

Don’t forget to follow us @INN_Australia for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

 

Cannabis Market Could Reach $5.5B By End Of Year

 
Experts Weigh In On Our Exclusive FREE Report. Can You Afford To Miss Out?
 

Cannabis research firm New Frontier Data has released a new report in which it projects that the value of the total cannabis industry will reach US$51 billion by the year 2025.

Also this week, a few cannabis companies announced new international ventures. This side of the space is full of potential, but is relatively new compared to markets like the US and Canada.

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“the Company”) today announced that it has officially launched its new cold storage services for 3rd party manufacturers with the onboarding of its first client, Kase Manufacturing (‘Kase’).

Kase will rent portions of TransCanna‘s 4,400 square foot, state-of-the-art cold storage cannabis freezer for specialized storage of Kase’s fresh-frozen cannabis biomass. The sub-40 degree Fahrenheit cannabis freezer, roughly the size of a five bedroom house, is the largest of its kind in Northern California.

Keep reading... Show less

Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company”), an established Canadian cannabis and vape retailer, is pleased to announce that further to its press release dated August 26, 2021, all of its issued and outstanding common shares (the “Common Shares”) will begin trading on a post-consolidation basis on September 17, 2021 at the commencement of trading on the TSX Venture Exchange (“TSXV”).

On August 26, 2021, the Company announced that the Common Shares would be consolidated on the basis of one (1) post-consolidation Common Share for each five (5) pre-consolidation Common Shares (the “Share Consolidation“).

Keep reading... Show less

 TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced that it has received pre-qualification approval for cultivation, processing and retail licenses from the state of Michigan’s Marijuana Regulatory Agency pursuant to the Medical Marihuana Facilities Licensing Act. The pre-qualification approval represents TerrAscend’s successful completion of the most comprehensive portion of the State’s licensing and regulatory approval process. The pre-qualification approval is a key closing condition for TerrAscend’s previously announced acquisition of Gage Growth Corp.(“Gage”) (the “Transaction”). The Transaction will close as soon as possible after receipt of the applicable shareholder, court and other regulatory approvals and satisfaction or waiver of all other conditions in the definitive arrangement agreement (the “Arrangement Agreement”).

Keep reading... Show less

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness Company offering premium probiotic supplements and products containing CBD, is pleased to announce it has increased the size of its previously announced non-brokered private placement from USD $2,000,000 to over USD $2,500,000 (the “Private Placement”). This increase is designed to accommodate additional demand that the Company has received in the financing.

Keep reading... Show less